GaryDHammerMDPhD

Adrenal Disease

Professor of Internal Medicine; Molecular & Integrative Physiology; Cell & Developmental Biology - University Mich Medical School

Join to view full profile

Dr. Hammer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hammer's full profile

Already have an account?

Office
1500 East Medical Center Dr
1ST floor Cancer Geriatrics Center
Ann Arbor, MI 48109
Phone+1 734-763-4876

Summary

Gary D. Hammer, M.D., Ph.D. is Professor in Departments of Internal Medicine (MEND), Cell & Developmental Biology, and Molecular & Integrative Physiology. He currently serves as Director of Endocrine Oncology Program in Rogel Cancer Center where he holds the Millie Schembechler Professorship in Adrenal Cancer. He is past Director of Center for Organogenesis: Stem Cells & Regenerative Medicine. He has brokered the recent renaissance of the current Michigan team of adrenal scientists that includes a who’s who in the study of adrenal disease. He received the UofM Jerome Conn Award for Outstanding Research in Internal Medicine, the Endocrine Society Edwin B. Astwood Award for Outstanding Research and is a member of ASCI and AAP. He has served in numerous leadership roles at UofM and in the public and private sectors including recent tenure on Board of Scientific Advisors for NCI. He is the editor of four textbooks including Pathophysiology of Disease: An Introduction to Clinical Medicine (McGraw Hilll), and the Adrenal Section Editor for Degroot’s Endocrinology (Elsevier). He has served in numerous capacities for the world’s largest endocrine organization, the Endocrine Society including his most recent role as President of the Society (2020-2021). An Advisor to the Congressional H.E.L.P. committee - he co-authored the 21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act’’ introduced in Congress in 2009. He has been catalyst for the formation of two international cooperative groups, most recently the A5 (American Australian Asian Adrenal Alliance) that leverages collaboration to secure projects from Pharma and funding agencies across the spectrum of adrenal diseases. He is a co- founder of two companies - MILLENDO and SLING THERAPEUTICS that focus on rare endocrine diseases.

Education & Training

University of California (San Francisco)Fellowship, Endocrinology, Diabetes, and Metabolism, 1994 - 1998
University of California (San Francisco)Residency, Internal Medicine, 1992 - 1994
Tufts University Sackler School of Graduate Biomedical SciencesPhD, 1985 - 1992
Tufts University School of MedicineClass of 1992
University of VermontBA, Psychology, Magna Cum Laude, 1981 - 1985

Certifications & Licensure

CA State Medical License 1993 - Present
MI State Medical License 2000 - 2026
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

Elected Member American Association of Physicians, 2012
The One Hundred, Inductee Massachusetts General Hospital Cancer Center, 2014
America's Top Doctors Castle Connolly, 2011-2014
Edwin B. Astwood Award Lecture for Outstanding Research in Endocrinology Endocrine Society, 2013
America's Top Doctors for Cancer Castle Connolly, 2011-2013
Inductee American Association of Physicians, 2012
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Elected Member The American Society for Clinical Investigation, 2008
Inductee American Society of Clinical Investigation, 2008
Outstanding Reviewer Award Molecular Endocrinology, 2005
Jerome Conn Award for Outstanding Research Department of Internal Medicine, University of Michigan, 2005
Millie Schembechler Endowed Chair of Adrenal Cancer University of Michigan, 2005
Award Winner 18th International Mouse Genome Conference Abstracts, 2004
Merck Senior Fellow Award Endocrine Society, 1999
Research Award Gordon Research Conference on Hormone Action, 1999
Outstanding Overall Teaching Contribution for Medical School-first Year, Nominee UCSF, 1998
Outstanding Small Group Instructor for Medical School-second Year, Nominee UCSF, 1998
Outstanding Clinical Preceptor for Medical School-second Year UCSF, 1998
Outstanding Small Group Instructor for Medical School-first Year, Nominee UCSF, 1995
Outstanding Achievement in Neuroscience Award Tufts University, 1992
Second Prize Earl P Charlton Student Research Scientist Competition, Tufts University, 1990
Third Prize School of Medicine Research Symposium, Tufts University, 1987
Kidder Medal for Outstanding Senior Male University of Vermont, 1985
Phi Beta Kappa Inductee 1985
Wasson Award for Outstanding Scholar-Athlete University of Vermont, 1985
Sigma Xi Inductee 1985
Outstanding Senior in Department of Psychology University of Vermont, 1985
Outstanding Contribution to Research in Psychology Award University of Vermont, 1984
Mortar Board Inductee 1984
Boulder Society Inductee University of Vermont, 1984
Join now to see all

Clinical Trials

IMC-A12 With Mitotane vs Mitotane Alone in Recurrent, Metastatic, or Primary ACC That Cannot Be Removed by Surgery Start of enrollment: 2008 Dec 01
Terminated
Phase 2

Publications & Presentations

PubMed

Non-canonical Wnt signaling triggered by WNT2B drives adrenal aldosterone production.
Kleiton S Borges, Donald W Little 3rd, Taciani de Almeida Magalhães, Claudio Ribeiro, Typhanie Dumontet
Biorxiv. 2024-08-24
1 citations
EndoBridge 2023: highlights and pearls.
Bulent Okan Yildiz, Cesar Luiz Boguszewski, Margaret Cristina da Silva Boguszewski, Luca Busetto, Ozlem Celik
Hormones. 2024-06-01
Chronic activation of adrenal Gq signaling induces Cyp11b2 expression in the zona fasciculata and hyperaldosteronism.
Desmaré van Rooyen, Antonio M Lerario, Donald W Little 3rd, Matthew R Ullenbruch, Matthew J Taylor
Molecular and Cellular Endocrinology. 2024-05-01

Journal Articles

Withanolides Are Potent Novel Targeted Therapeutic Agents against Adrenocortical Carcinomas
Subramanian C, Zhang H, Gallagher R, Hammer G, Timmermann B. and Cohen M, World Journal of Surgery, 6/1/2014
Abiraterone Acetate Added to Physiologic Hydrocortisone and Fludrocortisone Acetate Normalizes Androgen Excess in Adult Women With Classic 21-Hydroxylase Deficiency
Auchus RJ, Buschur EO, Chang AY, Hammer GD, Ramm C, Madrigal M, Wang G, Gonzalez M, Xu S, Smit JW, Jiao J and Yu MK, Journal of Clinical Endocrinology and Metabolism, 4/29/2014
Wnt-Signaling Inhibits Adrenal Steroidogenesis by Cell-Autonomous and Non-Ceell Autonomous Mechanisms
Walczak EM, Kuick,R, Finco I, Bohin, N, Hrycaj S, Wellick, D and Hammer G, Molecular Endocrinology, 1/1/2014
The Combination of Insulin-like Growth Factor Receptor 1 (IGF1R) Antibody Cixutumumab and Mitotane as a First-line Therapy for Patients with Recurrent/Metastatic Adren...
Lerario AM, Worden FP, Ramm CA, Hasseltine EA Stadler WM, Shah MH, Agamah E, Rao K and Hammer GD, Hormones and Cancer, 1/1/2014
Transcutaneous Biopsy of Adrenocortical Carcinoma Is Rarely Helpful in Diagnosis, Potentially Harmful, but Does Not Affect Patient Outcome
Williams A, Hammer GD, Else T, European Journal of Endocrinology, 1/1/2014
Pheochromocytoma in Clinical Decision Support
Else T and Hammer GD, Endocrinology & Metabolism, 1/1/2013
Adrenocortical Carcinoma in Clinical Decision Support
Else T and Hammer GD, Endocrinology & Metabolism, 1/1/2013
Adrenocortical Stem and Progenitor Cells - Implications for Adrenocortical Carcinoma
Simon DP and Hammer GD, Molecular Cellular Endocrinology, 3/1/2012
Treatment of Adrenocortical Carcinoma
Hammer GD and Lacroix A, Up To Date, 1/1/2012
Upregulated JAG1 Enhances Cell Proliferation in Adrenocortical Carcinoma
Simon DP, Giordano TJ and Hammer GD, Clinical Cancer Research, 1/1/2012
Mebendazole Monotherapy Provides Long-Term Disease Control in Metastatic Adrenocortical Carcinoma
Dobrosotskaya IY, Hammer GD, Schteingart DE, Maturen KE, and Worden FP, Endocrine Practice, 3/1/2011
Adrenocortical Stem and Progenitor Cells: Unifying Model of Two Proposed Origins
Wood MA and Hammer GD, Molecular and Cellular Endocrinology, 1/1/2011
LRH and Nanog Regulate Dax1 Transcription in Mouse Embryonic Stem Cells
Kelly VR and Hammer GD, Molecular and Cellular Endocrinology, 1/1/2011
Adjuvant and Definitive Radiotherapy for Adrenocortical Carcinoma
Sabolch A, Feng M, Griffith K, Hammer, G, Doherty G, and Ben-Josef E, Int. J. Radiation Oncology Biol. Phys, 1/1/2011
Aging Prop1 Deficient Dwarf Mice Maintain ACTH Production
Nasonkin OI, Ward RD Bavers DL, Beuschlein F, Mortensen AH, Keegan CE, Hammer GD and Camper SA, PLoS One, 1/1/2011
Inhibin-A Antagonizes TGFBeta2 Signaling by Downregulating Cell Surface Expression of the TGFBeta Co-receptor Betaglycan
Looyenga BD, Wiaters E, Vale WW and Hammer GD, Molecular Endocrinology, 1/1/2010
Dax1 Upregulates OCT4 Expression in Mouse Embryonic Stem Cells via LRH-1 and SRA
Kelly VR, Xu B, Koenig RJ and Hammer GD, Molecular Endocrinology, 1/1/2010
Safety, Tolerability, and Pharmacokinetics of the Anti-IGF-1R Monoclonal Antibody CP-751,871 in Patients with Refractory Adrenocortical Carcinoma
Haluska P, Worden F, Olmos D, Yinv D, Schteingart D, Batzel GN, Paccagnella ML, de Bono JS, Richardson RL, Gualberto AG and Hammer GD, Cancer Chemotherapy and Pharmacology, 1/1/2010
Efficient and Reversible Epigenetic Silencing of LINE-1 Retrotransposition Events in Embryonic Carcinoma Cells
Garcia-Perez JL, Morell M, Scheys JO, Kulpa DA, Morell S, Carter CC, Hammer GD, Collins KL, O'Shea KS, Menendez P and Moran JV, Nature, 1/1/2010
Proposal for Modification of the ENSAT Staging System for Adrenocortical Carcinoma Using Tumor Grade
Miller BS, Gauger PG, Hammer GD, Giordano TJ and Doherty GM, Langebeck's Archives of Surgery, 1/1/2010
Adjuvant Therapy in Patients With Adrenocortical Carcinoma: A Position of an International Panel
Berruti A, Fassnacht M, Baudin E, Hammer G, Haak H, Leboulleux S, Skogseid, B, Allolio B and Terzolo M, Journal of Clinical Oncology, 1/1/2009
Management of Adrenocortical Carcinoma
Strosberg JR, Hammer GD and Doherty GM, Journal of the National Comprehensive Cancer Network, 1/1/2009
Genetic P53 Deficiency Partially Rescues Adrencortial Dysplasia (ACD) Phenotype at the Expense of Increased Tumorigenicity
Else T, Kim AC, Trovoto A, Ferguson DO, Lucas PC and Hammer GD, Cancer Cell, 1/1/2009
In Search of Adrenocortical Stem and Progenitor Cells
Kim AC, Barlaskar FM, Heaton JH, Else T, Kelly VR, Krill KT, Scheys JO, Simon DP, Trovato A, Yang W-H, and Hammer GD, Endocrine Reviews, 1/1/2009
Preclinical Targeting of the Type I Insulin-like Growth Factor Receptor in Adrenocortical Carcinoma
Barlaskar FM, Spalding AC, Heaton JH, Davis MA, Ben-Josef E, and Hammer GD, JCEM, 1/1/2009
Join now to see all

Books/Book Chapters

Pathophysiology of Disease: An Introduction to Clinical Medicine
Editors: Hammer GD and McPhee SJ.LANGEEdition Seve,2014
CANCER: Principles & Practice of Oncology
Chapter: Adrenal Tumors
Lirov R, Else T, Lerario AM and Hammer GDEditors: DeVita, Jr. VT, Lawrence TS, and Rosenberg SA.Edition 10th,2014
Genetic Steroid Disorders
Editors: New ML, Lekarev O, Parsa O, Yuen, TT, O'Malley B, and Hammer GD.ELSEVIER2013
Genetic Steroid Disorders
Chapter: Adrenal Development
Xing Y, Achermann J and Hammer GDEditors: New ML, Lekarev O, Parsa O, Yuen, TT, O'Malley B, and Hammer GD.2013
Genetic Steroid Disorders
Chapter: Genetics of Adrenal Tumors
Lerario AM, Giordano TJ and Hammer GDEditors: New ML, Lekarev O, Parsa O, Yuen, TT, O'Malley B, and Hammer GD.2013
Basic Science and Clinical Concepts
Chapter: Adrenocortical Carcinoma
Editors: Else T and Hammer GD.SPRINGER2011
Adrenocortical Carcinoma: Basic Science and Clinical Concepts
Chapter: Adrenocortical Stem and Progenitor Cells: Implications for Cancer
Heaton JH and Hammer GDEditors: Else T and Hammer GD.2011
Adrenocortical Carcinoma: Basic Science and Clinical Concepts
Chapter: Overview of Treatment Options for Adrenocortical Carcinoma
Hammer GDEditors: Else T and Hammer, GD.2011
Pathophysiology of Disease: An Introduction to Clinical Medicine
Editors: McPhee SJ and Hammer GD.LANGEEdition Sixt,2010
Pathophysiology of Disease: An Introduction to Clinical Medicine
Chapter: Disorders of the Adrenal Cortex
Else T, Hammer, GD and McPhee SJEditors: McPhee, SJ, Hammer, GD.2010
Pathophysiology of Disease: An Introduction to Clinical Medicine
Chapter: Disorders of the Adrenal Medulla
Else T, Hammer GD and McPhee SJEditors: McPhee, SJ, Hammer, GD.2010
Pathophysiology of Disease: An Introduction to Clinical Medicine
Chapter: Disorders of the Hypothalamus and Pituitary Gland
Else T, Lingappa VR and Hammer GDEditors: McPhee, SJ, Lingappa, VR and Ganong, WF.2005
Encyclopedia of Stress
Chapter: Adrenocortical Function, Factors Controlling Development Thereof
Else T, and Hammer GDEditors: Fink, G.Elsevier Inc.Edition 2nd,2005
Endocrine Society Clinical Endocrinology Update
Chapter: Adrenal Neoplasms: Big and Small
Else T, and Hammer GDEditors: Endocrine Society Inc..2005
Endocrine Society Clinical Endocrinology Update
Chapter: ACTH-Independent Cushing's Syndrome
Wilhelm K and Hammer GDEditors: Endocrine Society Inc..2005
American Association of Clinical Endocrinologists Self-Assessment Program
Chapter: Physiology of the Hypothalamic-Pituitary-Adrenal Axis
Hammer GDEditors: Palumbo, P.J..AACE Self-Assessment Profile Committee2001
Join now to see all

Abstracts/Posters

Phase 1 Study of ATR-101 in Adrenocortical Carcinoma (ACC): ATR-101-001
Naing A, Habra M, Chugh R, Ijzerman M, Hesseltine E, Worden F, Phillips M, Smith D, The American Society of Clinical Oncology Abstracts, 1/1/2014
Adjuvant Radiotherapy Improves Local Control after Surgical Resection in Patients with Localized Adrenocortical Carcinoma: A Retrospective Cohort Study
Sabolch A, Else T, Jackson W, Griffith K, Miller B, Worden F, Williams A, Hammer GD, Jolly S, The Department of Radiation Oncology. University of Michigan, 1/1/2014
CDK7 Regulates Adrenal Development and Steroidogenesis in Mice
Xing Y, and Hammer GD, The Endocrine Society Annual Meeting Abstracts, 1/1/2014
ATR-101, a Selective ACAT1 Inhibitor in Development for Adrenocortical Carcinoma, Disrupts Steroidogenesis and Causes Apoptosis in Normal Canine Adrenals
Bailie MB, Phillips MD, Kerppola RE, Herman JR, Pearson PG, Hammer GD, Whitcomb R, Owens JC, and Hunt SW III, The Endocrine Society Annual Meeting Abstracts, 1/1/2014
ATR-101, a Selective and Potent Inhibitor of ACAT1, Causes Apoptosis in H295R ACC Cells
LaPensee CR, Hunt SW III, Rainey WE, and Hammer GD, The Endocrine Society Annual Meeting Abstracts, 1/1/2014
The Combination of Insulin-like Growth-Factor Receptor 1 (IGF1R) Antibody Cixutumumab and Mitotane As a First-Line Therapy for Patients with Recurrent/Metastatic Adren...
Lerario AM, Worden FP, Ramm CA, Hasseltine EA, Stadler WA, Shah MA, Agamah E, Rao K, and Hammer GD, The Endocrine Society Annual Meeting Abstracts, 1/1/2014
Radiographic Characteristics of Incidentalomas in Patients Later Diagnosed with Adrenocortical Cancer
Nogueira TM, Lirov R, Lerario AM, Hammer GD, Fragoso MCBV, Caoili EM, Else T, The Endocrine Society Annual Meeting Abstracts, 1/1/2014
Multiple Mechanisms of Wnt/Betacat-Mediated Inhibition of Adrenocortical Steroidogenesis
Walczak EM, Finco I, Bohin N, Kuick R, & Hammer GD, The Endocrine Society Annual Meeting Abstracts, 1/1/2014
Sonic Hedgehog in Adrenal Regeneration
Finco I, and Hammer GD, The Endocrine Society Annual Meeting Abstracts, 1/1/2014
International Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Linsitinib (OSI-906, L) in Patients (pts) with Locally Advanced or Metastatic Adrenocortic...
Fassnacht M, Baudin E, Berruti A, Demeure MJ, Fleege T, Poondru S, Quinn DI, Rorig R, Hammer GD, The Endocrine Society Annual Meeting Abstracts, 1/1/2014
Marked Androgen Reduction in Adult Women with Classic 21-hydroxylase Deficiency (21OHD) Treated with Abiraterone Acetate (AA) Added to Physiologic Hydrocortisone (HC) ...
Auchus RJ, Buschur E, Hammer GD, Chang AY, Ramm C, Madrigal D, Wang G, Gonzalez M, Xu S, Smit H, Poggesi I and Yu M, The Endocrine Society Annual Meeting Abstracts, 1/1/2013
Naturally Derived with Anolides Are Potent Novel Targeted Therapeutic Agents against Adrenocortical Carcinomas
Subramanian C, Zhang H, Hammer GD, Timmermann BN and Cohen MS, International Society of Endocrine Surgeons Abstract, 1/1/2013
Transcutaneous Biopsy of Adrenocortical Carcinoma Is Rarely Helpful in Diagnosis, Potentially Harmful, but Does Not Affect Patient Outcome
Williams A, Hammer GD and Else T, The Endocrine Society Annual Meeting Abstracts, 1/1/2013
Mutations in the DNA Mismatch Repair Genes Predisposes to Adrenocortical Carcinoma
Else T, Everett JN, Hammer GD, Gustafson SL Stoffel EM, Gruber SB, and Raymond VM, The Endocrine Society Annual Meeting Abstracts, 1/1/2013
Sumoylation of Sf1 Regulates Mice Adrenal Development
Xing Y, Zubair M, Ingraham H and Hammer GD, The Endocrine Society Annual Meeting Abstracts, 1/1/2013
Regulatory Effect Of Pod-1/Tcf21 In Sf-1/Nr5a1 Transcription Factor Of Pediatric And Adult Adrenocortical Tumor Cells
Franca MM, Ferraz-de-Souza B, Santos MG, Lerario AM, Fragoso MC, Latronico AC, Hammer GD and Lotfi CF, The Endocrine Society Annual Meeting Abstracts, 1/1/2013
Improved Local Control with Adjuvant Radiotherapy in Localized Adrenocortical Carcinoma: A Case-matched Retrospective Study
Sabolch A, Else T, Jackson W, Miller B, Worden F, Williams A, Hammer GD and Jolly S, American Society for Radiation Oncology Meeting Abstracts, 1/1/2013
Adrenocortical Carcinoma (ACC) Associated with Birt-Hogg-Dube Syndrome
Else T, Raymond VM, Long JC, Stoffel EM and Hammer GD, 1/1/2012
A Patient with PTEN Hamartoma Tumor Syndrome (PHTS) and Multiple Pulmonary Tumorlets and Carcinoids
Else T, Raymond VM, Long JC and Hammer GD, 1/1/2012
Patient and Disease Characteristics in a Single-Center Retrospective Study of 360 Adrenocortical Carcinoma (ACC) Patients
Else T, Williams A and Hammer G, The Endocrine Society Annual Meeting Abstracts, 1/1/2012
Abiraterone Acetate Added to Physiologic Hydrocortisone Dosing Safely Controls Androgen Excess in Adult Women with Classical 21-Hydroxylase Deficiency
Auchus RJ, Osborne E, Hammer GD, Chang AY, Ramm C, Madrigal D and Yu M, The Endocrine Society Annual Meeting Abstracts, 1/1/2012
Tcf21-Expressing Cells in the Adrenal Capsule Give Rise to Differentiated Adrenocortical Cells
Wood M, Garg I, Acharya A, Tallquist MD and Hammer GD, The Endocrine Society Annual Meeting Abstracts, 1/1/2011
Mechanism of Repression of the Fetal Adrenal Specific Enhancer (FAdE) of NrR5a1 by Dax1 In Vivo
Zubair M, Simon D, Finco I, Starnes E, Wood M, Heaton J and Hammer G, The Endocrine Society Annual Meeting Abstracts, 1/1/2011
Overexpression of the Hedgehog Pathway in Potential Adrenal Progenitor Cells
Finco I and Hammer GD, The Endocrine Society Annual Meeting Abstracts, 1/1/2011
Tissue-Microarray of Beta-Catenin in a Cohort of Pediatric and Adult Adrenocortical Tumors
Lima LO, Soares IC, Almeida MQ, Fragoso MCVB, Lerario AM, Ribeiro TC, Mariani TC, Hammer GD, Mendonca BB and Latronico AC, The Endocrine Society Annual Meeting Abstracts, 1/1/2010
Join now to see all

Lectures

Career Development Workshop - Communications Skills Lab: How to Communicate Your Work to Media and Lay Public
ENDO 2019 - New Orleans, LA - 3/23/2019
Early Career Forum
ENDO 2019 - New Orleans, LA - 3/22/2019
2019 Latin American Leadership Academy
ENDO 2019 - New Orleans, LA - 3/22/2019
Modeling Adrenal Tumorigenesis
ENDO 2019 - New Orleans, LA - 3/25/2019
Genotype/Phenotype Correlation in Adrenal Cancer
ENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/20/2018
Adrenal Carcinoma
ENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/19/2018
Debate: This House Believes that Adrenal Vein Sampling has a Major Role to Play in the Management of Patients with Primary Aldosteronism
ENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/18/2018
Lecturer, Cell and Developmental Biology 582: Organogenesis: Stem Cells to Regenerative Biology (Adrenal Module)
UMICH School of Medicine - 1/1/2015
Lecturer, Honors 252, Creativity in the Sciences and Arts (Adrenal Cancer)
UMICH LSA - 1/1/2014
Vulnerability and Presence in Science and Medicine
Clinical Trials Office - Comprehensive Cancer Cancer - 1/1/2014
Current Therapies for Adrenal Cancer
1/1/2014
ENDO 2013: The Endocrine Society’s 95th Annual Meeting & Expo 2013
The Endocrine Society, San Francisco, California - 6/15/2013
Bench to Bedside and Back Again, Plenary Speaker
1/1/2013
Translating Adrenal Stem Cells, Plenary Award Lecture
1/1/2013
Adrenal Tumors: Tip of the Iceberg
Global Hospital, Mumbai, India - 1/1/2013
Adrenal Tumors: Optimizing Management and Therapeutic Challenges in ACC Management
King Edward Memorial Hospital, Mumbai, India - 1/1/2013
Organogenesis of Adrenal Gland: Current Concepts
King Edward Memorial Hospital, Mumbai, India - 1/1/2013
Adrenal Cancer Current Therapeutics: Is There a Ray of Hope?
King Edward Memorial Hospital, Mumbai, India - 1/1/2013
Adrenal Cancer Molecular Genetics and Pathogenesis: My Understanding
King Edward Memorial Hospital, Mumbai, India - 1/1/2013
Adrenal Cancer, Keynote Speaker
1/1/2013
Career Day Speaker
1/1/2012
Adrenal Stem Cells; Plenary Speaker
Oakland University, Beaumont Health System and OUWB Institute for Stem Cell and Regenerative Medicin - 1/1/2012
Adrenal Insufficiency in Hospitalized Patients
1/1/2012
Lecturer, Translational Physiology, Molecular and Integrative Physiology
UMICH School of Medicine - 1/1/2012
Cell & Molecular Biology Retreat
1/1/2012
Join now to see all

Other

Adrenal Cancer
The Group Room Talk Radio 154
1/1/2007
Treatment of adrenocortical carcinoma
Hammer GD, Lacroix A
http://www.uptodate.com/contents/treatment-of-adrenocortical-carcinoma
UpToDate, Wolters Kluwer Health - 2013-02-01

Press Mentions

Gary D Hammer on the Improvement of Patient Care in Endocrine NeoplasiaDecember 23rd, 2019
Michigan Medicine's Division of Metabolism, Endocrinology and Diabetes Showcases New Research at Endocrine Society's ENDO 2018March 17th, 2018
Adrenal Disorders Experts Address Rare Conditions and Their Treatment at American Association of Clinical Endocrinologists Scientific and Clinical CongressMay 5th, 2017
Join now to see all

Grant Support

Wnt-Responsive Adrenocortical Cells In Organ Maintenance And CancerNational Cancer Institute2010–2012
Mechanisms Of Adrenal DifferentiationNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2012
Mechanisms Of Adrenal Cortex Growth/DifferentiationNational Institute Of Diabetes And Digestive And Kidney Diseases2000
Orphan Nuclear Receptors In Development And DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2000
Orphan Nuclear Receptors In Development And DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1999